Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ARCT compared with TXG: revenue, margins and what each company keeps, and the suppliers and customers both name
ARCT
Arcturus Therapeutics Holdings Inc.
Change
Mkt cap
Revenue
Revenue
TXG
10x Genomics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ARCT
Arcturus Therapeutics Holdings Inc.
vs
TXG
10x Genomics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ARCT, solid
TXG, dashed
ARCT
Arcturus Therapeutics Holdings Inc.
Change
9.37
· pre 9.37
· delayed
Mkt cap
$269.8M
Revenue
$18M
Q3 FY26
Revenue
$82M
FY25
TXG
10x Genomics, Inc.
Change
58.11
· pre 56.21
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$7.6B
Revenue
$151M
Q2 FY26
Revenue
$643M
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
ARCT
Arcturus Therapeutics Holdings Inc.
vs
TXG
10x Genomics, Inc.
9.37
pre 9.37
delayed
Price
58.11
pre 56.21
delayed
$269.8M
Mkt cap
$7.6B
Q3 FY26
$18M
Revenue
$151M
Q2 FY26
FY25
$82M
Revenue
$643M
FY25
Change
Change
ARCT
9.37
vs
TXG
58.11
Pre-market
Nov 6 '26
delayed